• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚胺培南与β-内酰胺类药物联合舒巴坦和克拉维酸在产β-内酰胺酶的脆弱拟杆菌菌株中的活性比较。

Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.

作者信息

Martín M A, Castillo A M, Liébana J, Marín A, Alados J C, Piédrola G

机构信息

Department of Microbiology, University School of Medicine, University of Granada, Spain.

出版信息

J Hyg Epidemiol Microbiol Immunol. 1991;35(2):189-97.

PMID:1940333
Abstract

We compared the "in vitro" activity of imipenem with 14 beta-lactams, both alone and in combination with clavulanic acid, and sulbactam against 110 beta-lactamase-producing strains of Bacteroides fragilis. The following antibiotics were tested: amoxycillin, penicillin, mezlocillin, piperacillin, cephalothin, cephazolin, cefamandole, cefmetazole, cefonicid, cefoxitin, cefotaxime, ceftazidime, ceftizoxime, and ceftriaxone. In all cases, except those of cefoxitin and cefmetazole, these combinations showed a statistically significant increase in beta-lactam activity, which was, however, never higher than that of imipenem, the antibiotic which performed best against Bacteroides fragilis.

摘要

我们比较了亚胺培南与14种β-内酰胺类抗生素单独使用以及与克拉维酸和舒巴坦联合使用时对110株产β-内酰胺酶的脆弱拟杆菌的“体外”活性。测试的抗生素如下:阿莫西林、青霉素、美洛西林、哌拉西林、头孢噻吩、头孢唑林、头孢孟多、头孢美唑、头孢尼西、头孢西丁、头孢噻肟、头孢他啶、头孢唑肟和头孢曲松。在所有情况下,除了头孢西丁和头孢美唑,这些联合用药显示β-内酰胺活性有统计学意义的增加,然而,其活性从未高于亚胺培南,亚胺培南是对脆弱拟杆菌效果最佳的抗生素。

相似文献

1
Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.亚胺培南与β-内酰胺类药物联合舒巴坦和克拉维酸在产β-内酰胺酶的脆弱拟杆菌菌株中的活性比较。
J Hyg Epidemiol Microbiol Immunol. 1991;35(2):189-97.
2
A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.第一代和第二代头孢菌素及其与β-内酰胺酶抑制剂联合用药对脆弱拟杆菌活性的比较研究。
Microbios. 1991;67(272-273):195-202.
3
Newer beta-lactam agents and the Bacteroides fragilis group.新型β-内酰胺类药物与脆弱拟杆菌群
Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S.
4
Increase in the activity of third-generation cephalosporins in combination with clavulanic acid and Sulbactam against Bacteroides fragilis.
Med Lab Sci. 1990 Jul;47(3):163-7.
5
[Detection of beta-lactamases in the Bacteroides fragilis group].[脆弱拟杆菌群中β-内酰胺酶的检测]
Pathol Biol (Paris). 1990 May;38(5):470-3.
6
[Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].[9种β-内酰胺类抗生素与克拉维酸或舒巴坦联合应用对亨利·蒙多医院分离出的产广谱β-内酰胺酶(CTX-1)肠杆菌科菌株的活性]
Pathol Biol (Paris). 1988 May;36(5):425-9.
7
Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.来自美国33个中心的737株脆弱拟杆菌属微生物的β-内酰胺酶产生情况、β-内酰胺敏感性以及与克拉维酸协同作用的耐药性
J Antimicrob Chemother. 1990 Sep;26(3):361-70. doi: 10.1093/jac/26.3.361.
8
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.β-内酰胺酶抑制剂YTR 830、克拉维酸和舒巴坦分别与氨苄西林和哌拉西林联合应用对产β-内酰胺酶厌氧菌的比较活性
J Chemother. 1989 Jul;1(4 Suppl):273-5.
9
Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains.拟杆菌属、卟啉单胞菌属和普雷沃菌属菌株对β-内酰胺类抗生素的耐药性及β-内酰胺酶的产生
Acta Microbiol Immunol Hung. 1995;42(3):287-99.
10
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.β-内酰胺类与β-内酰胺酶抑制剂三种组合(哌拉西林/他唑巴坦、替卡西林/克拉维酸和氨苄西林/舒巴坦)体外活性的比较评价
Braz J Infect Dis. 2000 Feb;4(1):22-8.